Padrão de Resistência aos Antibióticos entre Cepas de Serratia Marcescens Isoladas de Pacientes Imunossuprimidos
DOI:
https://doi.org/10.32635/2176-9745.RBC.1985v31n4.3360Keywords:
Immunossupresed Patients, Serratia, Nosocomial Infections, Bacterial ResistanceAbstract
Antimicrobial susceptibility of 47 strains of Serratia from immunossupresed patients, was studied by using disk sensitivity. Most of the strains were resistant to ampicillin, carbenicillin and chloramphenicol. Cephalotin was active only against 26% of the strains. Among the tested drugs, amikacin, tobramycin, gentamicin and colistin were active against the tested strains.
Downloads
References
Dodson WH: Serratia marcescens septicemia. Arch Inter. Med. 1968; 121: 145. DOI: https://doi.org/10.1001/archinte.1968.03640020033006
Ewing WH, Jonhnson JG, Davis BR: The occurrence of Serratia marcescens in nosocomial infections. CDC. 1962; Atlanta Ga.
Wilfert JN, Barret FF, Kass EH; Bacteremia due to Serratia marcescens. N. Engl. J. Med. 1968; 279: 286. DOI: https://doi.org/10.1056/NEJM196808082790604
Sanders CV. Luby JP, Johanson WG Jr: Serratia marcescens infections from inhalation therapy medications. Ann. Intern. Med. 1970; 73: 15. DOI: https://doi.org/10.7326/0003-4819-73-1-15
Bodey GP, Rodrigues V, Smith JP; Serratia sp. infections in cancer patients. Cancer, 1970; 25: 199. DOI: https://doi.org/10.1002/1097-0142(197001)25:1<199::AID-CNCR2820250128>3.0.CO;2-4
Bermudez LE, Vidal E: Sensibilidade de 1.156 cepas de Enterobactérias à carbenicilina e cefalotina. Rev. Bras. Patol. Clin. 1984; 20: 107.
O' Brien TF. Acari JF, Medeiros AA, et al: International comparison of prevalence of resistence to antibiotics. JAMA 1978; 239: 1518. DOI: https://doi.org/10.1001/jama.1978.03280420054018
Shaefler S, Winter J, Catelli A. et al: Specific distribution of R factors among Serratia marcescens strains isolated from hospital infections. AppI. Microbial. 1971; 22: 399. DOI: https://doi.org/10.1128/am.22.3.339-343.1971
Meyer RD, Lewis RP, Halter J, et al: Gentamicin-resistent. Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet. 1976; 1: 580. DOI: https://doi.org/10.1016/S0140-6736(76)90370-6
Cooksey R. Bannister E, Farrar E Jr: Antibiotic resistence patterns of clinical isolates of Serratia marcescens. Antimicrob. Agents Chemother, 1975; 7: 396. DOI: https://doi.org/10.1128/AAC.7.4.396
Medeiros AA, O'Brien TF: Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia. Antimicrob. Agents Chemother. 1969; 2: 30.
Kurtz T, Winston DJ, Brukner DA, et al; Comparativa in vitro synergistic activity of new beta-lactam antibiotics and amikacin against P. aeruginosa and S. marcescens. Antimicrob. Agents Chemother. 1981; 20: 239. DOI: https://doi.org/10.1128/AAC.20.2.239
Krieger JN, Kaiser DL, WenzeI RP; Urinary tract etiology of bloodstrean infections in hospitalized patients. J. Infect. Dis. 1983; 148; 57. DOI: https://doi.org/10.1093/infdis/148.1.57
Bermudez LE, Panza M, Vidal E; Análise dos fatores relacionados à incidência de infecções urinárias em pacientes com câncer. Rev. Bras. Cancerol. 1983; 29: 26.
